Content Section
|
Medicare Information Resource
|
Note: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material which is copyrighted by the American Medical Association (AMA). You are forbidden to download the files unless you read, agree to and abide by the provisions of the copyright statement. Read the copyright statement now (you will be linked back to here).
|
MIR-2006-10AB, October 2006
Medicare Part B Drug Competitive Acquisition Program (CAP) Additions to Approved CAP Vendor’s Drug List Effective October 1, 2006; Information on Price File Updates
Provider Types Affected
Physicians participating in the Medicare Part B Drug CAP
Impact on Providers
This Special Edition article is being provided to inform physicians participating in the CAP program that, effective October 1, 2006, drugs are being added to the CAP drug table.
Background
The list of drugs supplied under the CAP is subject to quarterly updates, and this Special Edition article is being provided by the Centers for Medicare & Medicaid Services (CMS) to inform you of additions to the CAP drug list (Per Change Request (CR) 5079, Business Requirements (BRs) 5079.3 and 5079.4). For more details, see the related MLN Matters article, MM5079, at http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5079.pdf  on the CMS Web site.
Effective October 1, 2006, the CAP designated carrier will add the drugs listed in the following table to the CAP drug table, and the following Healthcare Common Procedure Coding System (HCPCS ) codes will be available through the CAP:
| HCPCS Code |
Descriptor |
J3240 |
Injection, Thyrotropin Alpha, 0.9 mg, provided in 1.1 mg vial (trade name Thyrogen®) |
J9160 |
Denileukin Diftitox, 300 MCG (trade name Ontak®) |
J9010 |
Alemtuzumab, 10 MG (trade name Campath®) |
An updated CAP drug list, which includes the drugs listed above and updates to the NDC codes available through the CAP, will be posted on the Approved CAP vendor page of the CMS CAP Web site (http://www.cms.hhs.gov/CompetitiveAcquisforBios/15_Approved_Vendor.asp#TopOfPage ) and on the approved CAP vendor’s Web site ( http://www.bioscrip.com/) on or about September 1, 2006.
Additional Information
If you have any questions, please contact your carrier at their toll-free number, which may be found on the CMS Web site at: http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip. 
Disclaimer
This article was prepared as a service to the public and is not intended to grant rights or impose obligations. This article may contain references or links to statutes, regulations, or other policy materials. The information provided is only intended to be a general summary. It is not intended to take the place of either the written law or regulations. We encourage readers to review the specific statutes, regulations and other interpretive materials for a full and accurate statement of their contents.
MLN Matters Number: SE0658
Related Change Request (CR) #: N/A
Effective Date: N/A
|
